T cell receptor beta variable 7-7 (TRBV7-7)

T cell receptor beta variable 7-7 (TRBV7-7) encodes the *variable domain of the beta chain* of the T cell receptor (TCR), a cell surface heterodimeric complex present on T lymphocytes[2]. The TCR is essential for adaptive immunity, recognizing antigen-derived peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells[3]. The variable domains of the TCR (including TRBV segments) determine antigen specificity through somatic V(D)J recombination during T cell development, generating a vast repertoire of distinct T cells, each with a unique antigen-binding site[2][5]. Upon binding peptide-MHC, the TCR initiates intracellular signaling for T cell activation, proliferation, and effector function in immune responses[3]. The TRBV7-7 segment is one of many variable segments contributing to the beta chain diversity and function, and does not operate independently as a therapeutic target, drug target, or biomarker, but as part of the larger TCR structure. Manipulation of the TCR complex, including its beta variable regions, underlies therapeutic strategies in immunotherapy and disease monitoring[3].

Other names

T cell receptor beta variable 7-7TRBV7-7TRBV77TCRBV7S7TCRBV6S6A2TV_segment translation productTVB77 protein

Drugs or biologics targeting T cells act via: - Blocking/inhibiting TCR signaling - Engaging or engineering TCRs for antigen-specific cytotoxicity - Modifying T cell activation thresholds (e.g., checkpoint inhibitors)